U.S. Pauses J&J Covid-19 Shot at Critical Point in Vaccination Effort

U.S. Pauses J&J Covid-19 Shot at Critical Point in Vaccination Effort

By The Wall Street Journal

P.M. Edition for April 13. Use of the Johnson & Johnson coronavirus vaccine is on hold in the U.S., as regulators investigate rare cases of blood clots. The pause comes at a critical time, as vaccination efforts ramp up to get ahead of new variants of the virus. Health and medicine editor Jonathan Rockoff joins host Annmarie Fertoli to discuss the potential impact. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
-
Heart UK
Mute/Un-mute